英创远达制药 CASI 深 沪
已收盘 08-01 16:00:00 美东时间
1.29
-0.010
-0.77%
华盛通- 最 高1.355
- 今 开1.29
- 成交量 1.43万股
- 最 低 1.25
- 昨 收 1.30
- 总市值 1998.57万
- 52周最高 7.67
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.0909
- 委 比 -29.50%
- 总股本 1549.28万
- 历史最高 88.92
- 量 比 0.24
- 振 幅 8.08%
- 历史最低 1.0909
- 每 手 1
- 风险率 1.55%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多CASI Pharmaceuticals Appoints David Cory as CEO to Drive CID-103 Program
CASI Pharmaceuticals ( ($CASI) ) has issued an announcement. On July 21, 2025, ...
07-22 18:28
CASI Pharmaceuticals announces CEO appointment
CASI Pharmaceuticals (NASDAQ:CASI) has named David Cory as its new chief executive officer and board member. Wei-Wu He, Ph.D., will step down as CEO and transition to the role of executive chairman of...
07-22 04:21
ISS National Lab's Orbital Edge Accelerator Program Selects Six Startups
Each startup to receive up to $500,000 in investment and future research opport...
07-17 03:58
Why Is Dyne Therapeutics Stock Trading Lower On Tuesday?
Dyne updates DYNE-101 trial timeline, reports strong 12-month data, and receives FDA Breakthrough Therapy status for treating DM1.
06-17 22:56
美股大行评级 | 摩根大通：维持网易"超配"评级，目标价升至135美元；瑞银上调达美航空评级至"买入"
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1131517965561573377.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Armata Pharmaceuticals(ARMP)"买入"评级，目标价从7美元升至9美元</p> <p>• 瑞银：维持爱芬奇(ANF)"买入"评级，目标价从115美
05-20 09:28
HC Wainwright & Co. Reiterates Buy on CASI Pharmaceuticals, Maintains $4 Price Target
HC Wainwright & Co. analyst Sean Lee reiterates CASI Pharmaceuticals (NASDAQ:CASI) with a Buy and maintains $4 price target.
05-19 18:43
CASI Pharmaceuticals Q1 EPS $(0.69) Misses $(0.61) Estimate, Sales $6.24M Beat $6.10M Estimate
CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.61) by 13.11 percent. This is a 2.82 percent increase over losses of $(0.71) per share
05-17 06:06
CASI Pharmaceuticals Announces CFO Transition
The latest announcement is out from CASI Pharmaceuticals ( ($CASI) ). On May 14...
05-15 05:28
G-SHOCK AND CROCS LAUNCH FIRST-EVER COLLABORATION: WHERE LEGENDARY TOUGHNESS MEETS STREET-READY DESIGN
Limited-edition collection debuts glow-in-the-dark Echo Wave and a convertible G-SHOCK timepiece DOVER, N.J., May 13, 2025 /PRNewswire/ -- Today, Casio America, Inc. is excited to announce a...
05-13 23:41
Century Casinos, Inc. Announces First Quarter 2025 Results
Solid First Quarter Considering Severe Weather Impacts. Remainder of 2025 Looks Promising After Opening of New Land-Based Casino in Missouri and Reopening of the Wroclaw Casino in Poland. CO...
05-12 18:00
